Helsinn nomina Mary Lynne Hedley nel Consiglio di Amministrazione

29 April 2021

Helsinn Announces the Launch of Adlumiz® (anamorelin) for the Treatment of Cancer Cachexia in Japan

21 April 2021

Helsinn announces poster presentation at Academy of Managed Care Pharmacy (AMCP)2021 Virtual Meeting evaluating healthcare resource utilization in CINV

13 April 2021

BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology

31 March 2021

“Banche e industria, un binomio vincente nella crisi pandemica”– Tavola rotonda online, ospite il presidente di FIT Giorgio Calderari

25 March 2021

Corriere del Ticino “La crisi si può superare solo con il gioco di squadra” Tavola rotonda Abt, ospite il presidente di FIT, Giorgio Calderari

25 March 2021

La Regione “Covid, un’economia comunque resiliente” Tavola rotonda Abt, ospite il presidente di Farma Industria Ticino, Giorgio Calderari

25 March 2021

3B FUTURE HEALTH GP S.A.R.L. ANNOUNCES THE LAUNCH OF 3B FUTURE HEALTH FUND II

24 March 2021

Taiho Pharmaceutical Submits New Drug Application for NK1 Receptor Antagonist Fosnetupitant for Prevention of Gastrointestinal Symptoms (Nausea and Vomiting) Associated with Cancer Chemotherapy

23 March 2021

Gain Therapeutics Announces Pricing of Initial Public Offering of Common Stock

22 March 2021